Dreamtech’s electronic nose that can check whether a patient has contract COVID-19 has received the European Commission's CE registration for diagnostic tool, the company said on Friday.
It opens the door for the company sell the product in Europe
The electronic nose was co-developed with Israeli firm Nanoscent, It can check whether a patient has contracted COVID-19 by analyzing their breath. It detects volatile organic compound in their breath for that.
Dreamtech said the solution has a sensitivity of around 90% and can detect the virus even from asymptomatic patients.
Dreamtech and Nanoscent plan to modulate the device and pair it with designated breathing bags.
They will supply 500 of the devices and 100,000 bags by August to clients.
Dreamtech invested a million dollars in Nanoscent in March last year, to become the exclusive vendor for the electronic nose solution.
